Boehringer Ingelheim Animal Health Overview
Pro stress-test →Boehringer Ingelheim Animal Health operates as the second-largest animal health company in the U.S., powered by over 3,000 individuals across key locations including Georgia, Missouri, Iowa, Minnesota, New Jersey, and Puerto Rico. Its extensive animal-health portfolio features highly regarded vaccines, parasite-control products, and pharmaceuticals designed to protect both pets and livestock from disease.
Strategic Profile
Pro stress-test →The company is an integral part of a larger, family-owned global group founded in 1885 in Germany, also specializing in human pharmaceuticals and biopharmaceutical contract manufacturing. Boehringer Ingelheim acquired Merial, uniting the legacies, deep expertise, and broad product portfolios of the two into one of the world's leading animal health companies.
Competitive Landscape
Pro stress-test →Competitors of Boehringer Ingelheim Animal Health include Alltech, Ceva, Advanced Animal Diagnostics, Dechra, Heska and others. The company competes in vaccine development, parasite control, and therapeutic solutions across companion animal and livestock segments with established product brands like NexGard and Ivomec.
Industry Context
Boehringer Ingelheim Animal Health operates in Animal Health / Veterinary Pharmaceuticals.
Key facts
Founded: 1885 · Headquarters: Ingelheim am Rhein, Germany · Employees: 3,000+ · Revenue: $440.4M (U.S. business)